Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3 on the study page, indicating a minor maintenance update such as bug fixes or formatting adjustments; no substantive changes to the study content are implied.SummaryDifference0.1%

- Check16 days agoChange DetectedThe Revision tag on the page changed from v3.6.0 to v3.6.2. This indicates a minor update to the page's underlying system and content.SummaryDifference0.1%

- Check30 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note indicating enrollment is closed; the Intervention/Treatment heading formatting was normalized and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check38 days agoChange DetectedThe page shows a revision indicator updated from v3.5.4 to v3.5.5, signaling a minor software release rather than a content change.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.5.4 was added and v3.5.3 was removed, indicating an internal update to the page's template/versioning. There are no changes described to displayed study information.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor update to the page's versioning rather than substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.